Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P003 Metabolomics for improved patient stratification in inflammatory bowel disease: Characterisation of the ulcerative colitis metabolome

ECCO'20 Vienna

Year: 2020
Authors:

J. Diab1, T. Hansen1, R. Goll2,3, H. Stenlund4, E. Jensen1, T. Moritz4,5, J. Florholmen2,3, G. Forsdahl1

1Department of Pharmacy, Faculty of Health Sciences, University of Tromsø The Arctic University of Norway, Tromsø, Norway, 2Department of Clinical Medicine, Faculty of Health Sciences, University of Tromsø The Arctic University of Norway, Tromsø, Norway, 3Department of Medical Gastroenterology, University Hospital of North Norway, Tromsø, Norway, 4Department of Molecular Biology, Swedish Metabolomics Center, Umeå University, Umeå, Sweden, 5The Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Copenhagen, Denmark

P004 PN-943, an oral α4β7 integrin antagonist, inhibits MAdCAM1-mediated proliferation and cytokine release from CD4+ T cells independent of trafficking

ECCO'20 Vienna

Year: 2020
Authors:

L. CHENG, S. Venkataraman, L. Zhao, L. Lee, T. Tang, D. Liu, L. Mattheakis

Department of Biology, Protagonist Therapeutics, Newark, USA

P005 Regulators of the guanylate cyclase pathway are potential novel markers of mucosal healing in IBD

ECCO'20 Vienna

Year: 2020
Authors:

L.E. Jeffery1, U.N. Shivaji1, D. Zardo2, A. Acharjee3, O.M. Nardone4, S.C. Smith4, G. Gkoutos3, S.S. Visweswariah5, S. Ghosh1, M. Iacucci1

1NIHR Birmingham Biomedical Research Centre, University of Birmingham, Gastroenterology, Birmingham, UK, 2University Hospitals Birmingham, Pathology, Birmingham, UK, 3Department of Gastroenterology, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK, 4Department of Gastroenterology, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK, 5Department of Molecular Reproduction, Development and Genetics, Indian Institute of Science, Bangalore, India

P006 3D Multicellular intestine-on-a-chip model for disease modelling and drug discovery

ECCO'20 Vienna

Year: 2020
Authors:

G. Lo Sasso1, L. Gijzen2, D. Marescotti1, E. Naumovska2, E. Raineri2, A. Nicolas2, H. Lanz2, D. Guerrera1, R. van Vught2, J. Joore2, P. Vulto2, M.C. Peitsch1, J. Hoeng1, D. Kurek2

1Department of System Toxicology, Philip Morris Products SA, Neuchâtel, Switzerland, 2Mimetas BV, Leiden, The Netherlands

P007 GC1qR driven oxidative phosphorylation is essential for intestinal goblet cell differentiation

ECCO'20 Vienna

Year: 2020
Authors:

A. SÜNDERHAUF1, M. Hicken1, K. Skibbe1, H. Schlichting1, M. Hirose2, S. Perner3, S. Ibrahim2, S. Derer1, C. Sina1

1Institute of Nutritional Medicine, University Hospital Schleswig-Holstein, Lübeck, Germany, 2Lübeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany, 3Institute of Pathology, University Hospital Schleswig-Holstein, Lübeck, Germany

P008 Whole-genome RNA sequencing in collagenous colitis: a subgroup analysis

ECCO'20 Vienna

Year: 2020
Authors:

C. Escudero-Hernández1, A. van Beelen Granlund2, T. Bruland3, A.K. Sandvik4, S. Koch5, A.E. Østvik3, A. Münch6

1Department of Biomedical and Clinical Sciences BKV, Linköping University, Linköping, Sweden, 2Centre of Molecular Inflammation Research and Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology NTNU, Trondheim, Norway, 3Department of Clinical and Molecular Medicine and Department of Gastroenterology and Hepatology, Norwegian University of Science and Technology NTNU, Trondheim, Norway, 4Centre of Molecular Inflammation Research, Department of Clinical and Molecular Medicine and Department of Gastroenterology and Hepatology, Norwegian University of Science and Technology NTNU, Trondheim, Norway, 5Department of Biomedical and Clinical Sciences BKV and Wallenberg Center for Molecular Medicine WCMM, Linköping University, Linköping, Sweden, 6Division of Gastroenterology and Hepatology, Department of Biomedical and Clinical Sciences BKV, Linköping University, Linköping, Sweden

P009 The innate cytokines IL-1α and TNF-α induce the expression of Oncostatin M and its type II receptor in human colonic subepithelial myofibroblasts

ECCO'20 Vienna

Year: 2020
Authors:

E. Filidou1, G. Kokkotis2, G. Tarapatzi1, M. Boulkou3, K. Arvanitidis1, I. Drygiannakis3, V. Valatas3, I. Koutroubakis3, S. Vradelis4, G. Kolios1, G. Bamias2

1Laboratory of Pharmacology, Department of Medicine, Democritus University of Thrace, Alexandroupolis, Greece, 2GI Unit, 3rd Academic Department of Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece, 3Laboratory of Gastroenterology, Department of Medicine, University of Crete, Heraklion, Greece, 4University Hospital of Alexandroupolis, Democritus University of Thrace, Alexandroupolis, Greece

P010 Measurement of colonic mucosal content of biologics with the use of magnetic resonance imaging (MRI): A pilot study in patients with ulcerative colitis

ECCO'20 Vienna

Year: 2020
Authors:

R. Filip1, P. Bar2, D. Bartusik-Aebisher3, D. Aebisher3

1Kliniczny Szpital Wojewodzki Nr 2 im. Sw. Krolowej Jadwigi w Rzeszowie, Klinika Gastroenterologii i Centralna Pracownia Endoskopii, Rzeszow, Poland, 2Department of Gastroenterology with IBD Unit, Clinical Hospital 2- Rzeszów- Poland, Rzeszow, Poland, 3University of Rzeszow, Medical Faculty, Rzeszow, Poland

P011 Dysbiosis and Goblet cells depletion triggers early intestinal barrier dysfunction that precedes gut inflammation in IL-10 deficient mice (IL-10−/−)

ECCO'20 Vienna

Year: 2020
Authors:

B. López Cauce1, M. Puerto1, J.J. García2, J. Miranda-Bautista1, J. Vaquero1, R. Bañares1, L. Menchén1

1Department of Gastroenterology and Digestive System Medicine, General University Hospital Gregorio Marañón, Madrid, Spain, 2Department of Microbiology and Parasitology, Pharmacy Faculty of Complutense University of Madrid, Madrid, Spain

P012 α4β7 Receptor occupancy by vedolizumab at trough time-point occurs at the membranal level and is not associated with endoscopic healing in inflammatory bowel disease patients

ECCO'20 Vienna

Year: 2020
Authors:

B. Ungar1,2, Z. Ben-Shatach1,2, O. Haj-Natour1,2, M. Yavzori1,2, E. Fudim1,2, O. Picard1,2, D. Coscas1,2, A. Lahat1,2, M. Lidar2,3, R. Eliakim1,2, U. Kopylov1,2, S. Ben-Horin1,2

1Sheba Medical Center Tel Hashomer, Gastroenterology Institute, Ramat gan, Israel, 2Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel, 3Sheba Medical Center Tel Hashomer, Rheumatology Institute, Ramat gan, Israel

P013 The JAK-3 and TYK-2 / STAT pathways are activated in moderate to severe ulcerative colitis

ECCO'20 Vienna

Year: 2020
Authors:

M. Loza1, J.M. Brea1, C. Calviño-Suarez2, I. Baston-Rey2, R. Ferreiro-Iglesias2, J.E. Dominguez-Munoz2, M. Barreiro-de Acosta2

1BioFarma Research Group, CIMUS Research Center and IDIS Health Research Institute, Department of Pharmacology, Santiago de Compostela, Spain, 2Department of Gastroenterology, IBD Unit, University Hospital Santiago De Compostela CHUS, Santiago De Compostela, Spain

P014 Identification of Crohn’s disease immunopathotypes

ECCO'20 Vienna

Year: 2020
Authors:

H.M. Baer1, E. MacDonald2, A. Ferguson1, A.M. Scott3, M.I. Khan3, K.A. Bain1, U.Z. Ijaz4, J. Cole1, M. Ramanujam5, R.J.B. Nibbs1, D.R. Gaya3, S.W.F. Milling1

1Institute of Infection, Inflammation and Immunity, College of Medical, Veterinary and Life Sciences, University of Glasgow, Immunobiology, Glasgow, UK, 2Medical Research Institute, QIMR Berghofer, Immunology in Cancer and Infection, Brisbane, Australia, 3Gastroenterology Unit, Glasgow Royal Infirmary, Gastroenterology, Glasgow, UK, 4Rankine Building,- School of Engineering, University of Glasgow, Microbial Informatics, Glasgow, UK, 5Boehringer Ingelheim Pharmaceuticals Inc., Immunology and Respiratory Diseases Research, Ridgefield, USA

P015 Tricellulin overexpression protects against elevated macromolecule uptake in DSS colitis mice

ECCO'20 Vienna

Year: 2020
Authors:

F. WEIß1, I.F.M. Lee1, A. Fromm1, J.C.E. Hu1, T. Breiderhoff2, M. Fromm1, J.D. Schulzke1, S.M. Krug1

1Charité, Universitätsmedizin Berlin, Institute of Clinical Physiology, Berlin, Germany, 2Charité, Department of Pediatrics, Division of Nephrology, Universitätsmedizin Berlin, Berlin, Germany

P016 Efficiency of evaluating the expression of Toll-like receptors 2, 4, 6 and proteins proteomic profiling as integral indicators for predicting the risk of early relapse of ulcerative colitis

ECCO'20 Vienna

Year: 2020
Authors:

G. Tarasova, A. Volkov, A. Iakovlev, T. Ghazudin, I. Shcherbakova

Department of Gastroenterology, Rostov State Medical University, Rostov-on-Don, Russian Federation

P017 C86/CD16 macrophages accumulate in the mucosa of B3 patients and could mediate EMT in Crohn’s disease

ECCO'20 Vienna

Year: 2020
Authors:

A. Boronat-Muñoz1, A. Cejudo-Garces1, P. Lledo-Gil1, J. Cosín-Roger2, S. Coll3, F. Navarro-Vicente4, R. Alos5, S. Calatayud6, M.D. Barrachina6, D. Ortiz-Masiá7

1Department of Medicine, Universidad de Valencia, Valencia, Spain, 2FISABIO, Hospital Dr Peset, Valencia, Spain, 3Department of Pharmacy, Universidad de Valencia, Valencia, Spain, 4Hospital de Manises, Cirugía General y Digestiva, Manises, Spain, 5Hospital la Fe, Cirugía General y Digestiva, Valencia, Spain, 6Department of Pharmacy and CIBERehd, Universidad de Valencia, Valencia, Spain, 7Department of Medicine and CIBERehd, Universidad de Valencia, Valencia, Spain

P018 Per- and polyfluoroalkyl substances (PFAS) are significantly increased in patients with late-onset of ulcerative colitis

ECCO'20 Vienna

Year: 2020
Authors:

F. Fart1, S. Salihovic1,2, A. McGlinchey1, M. Orešič1,3, J. Halfvarson4, T. Hyötyläinen2, I. Schoultz1

1School of Medical Sciences, Örebro University, Örebro, Sweden, 2School of Science and Technology, Örebro University, Örebro, Sweden, 3Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland, 4Department of Gastroenterology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden

P019 Colonic mucosal kinase activity, cytokine and chemokine profiles in inflammatory bowel disease

ECCO'20 Vienna

Year: 2020
Authors:

E. Brand1, B. Roosenboom2, B. Malvar Fernandez3, L. Lutter1, E. van Koolwijk4, E.G. van Lochem4, C.S. Horjus Talabur Horje2, K.A. Reedquist3, F. van Wijk3, B. Oldenburg5

1Department of Gastroenterology and Hepatology and Centre for Translational Immunology, University Medical Centre Utrecht, Utrecht, The Netherlands, 2Department of Gastroenterology and Hepatology, Rijnstate Crohn and Colitis Centre, Arnhem, The Netherlands, 3Centre for Translational Immunology, University Medical Centre Utrecht, Utrecht, The Netherlands, 4Department of Microbiology and Immunology, Rijnstate Hospital, Arnhem, The Netherlands, 5Department of Gastroenterology and Hepatology, University Medical Centre Utrecht, Utrecht, The Netherlands

P020 MAM, an anti-inflammatory protein derived from Faecalibacterium prausnitzii as a biomarker in Crohn’s disease?

ECCO'20 Vienna

Year: 2020
Authors:

P. McLellan1, A. Lavelle1, L. Brot1, M. Straube1, L. de Sordi1, J.P. Grill1, A. Bourrier2, J. Kirchgesner2, J.M. Chatel3, L. Beaugerie2, H. Sokol1, P. Seksik1

1INSERM, Pierre and Marie Curie University, CRSA UMRS_938 Team Microbiota Intestine and Inflammation, Paris, France, 2Saint Antoine Hospital, Department of Gastroenterology, Paris, France, 3INRA, Micalis, Jouy-enJosas, France

P021 The influence of short-chain fatty acids produced by commensal bacteria on macrophage phenotype

ECCO'20 Vienna

Year: 2020
Authors:

C. Jukes1,2, L. Ricci3, E. von Coburg1,2, M. Nasr4, A.W. Walker3, S.H. Duncan3, A.N. Hegazy MD, PhD1,2

1Charité, University Medicine Berlin, CBF and German Rheumatism Research Center-Berlin, Department of Gastroenterology, Infectiology and Rheumatology, Berlin, Germany, 2Deutsches Rheuma-Forschungszentrum- ein Institut der Leibniz-Gemeinschaft, Inflammatory Mechanisms Group, Berlin, Germany, 3Rowett Institute, University of Aberdeen, Gut Health Group, Aberdeen, UK, 4Department of Pharmaceutics and Industrial Pharmacy, Ain Shams University, Faculty of Pharmacy, Cairo, Egypt

P022 Impact of increasing disease symptom concordance between patients with inflammatory bowel disease and their physicians: insights from US, France, Germany, Italy, Spain and UK (5EU)

ECCO'20 Vienna

Year: 2020
Authors:

J. Kershaw1, R. Wild1, R. Lukanova1, S. Bruce Wirta2, M. Sikirica3

1Adelphi Real World, Adelphi, Manchester, UK, 2Janssen-Cilag, Janssen, Solna, Sweden, 3Janssen Scientific Affairs, LLC, Janssen, Horsham- PA, USA